DenovAI Biotech is a company headquartered in Israel.
DenovAI Biotech develops AI-driven platforms for de novo protein design to create therapeutic antibodies, small protein and peptide biologics, and diagnostic reporters. The company is based in Rehovot, Israel and is a portfolio company of AION Labs.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.